HRAS and adenocarcinoma: However, the consistent finding of a mutational pattern involving p53, PIK3CA and HRAS which is in good agreement with data presented before [15] in the group of SDC but not in the adenocarcinoma NOS cases further indirectly validates our diagnostic classification.